BridgeBio Pharma Inc (BBIO)
28.74
+1.04
(+3.75%)
USD |
NASDAQ |
May 09, 16:00
28.71
-0.03
(-0.10%)
After-Hours: 20:00
BridgeBio Pharma Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2021 | 152.08 |
| March 29, 2021 | 146.88 |
| March 26, 2021 | 156.45 |
| March 25, 2021 | 162.42 |
| March 24, 2021 | 157.61 |
| March 23, 2021 | 169.24 |
| March 22, 2021 | 177.78 |
| March 19, 2021 | 174.05 |
| March 18, 2021 | 163.27 |
| March 17, 2021 | 176.52 |
| March 16, 2021 | 175.05 |
| March 15, 2021 | 179.78 |
| March 12, 2021 | 182.48 |
| March 11, 2021 | 183.20 |
| March 10, 2021 | 179.35 |
| March 09, 2021 | 166.95 |
| March 08, 2021 | 153.01 |
| March 05, 2021 | 160.05 |
| March 04, 2021 | 160.83 |
| March 03, 2021 | 164.38 |
| March 02, 2021 | 170.21 |
| March 01, 2021 | 184.98 |
| February 26, 2021 | 181.82 |
| February 25, 2021 | 167.54 |
| February 24, 2021 | 173.40 |
| Date | Value |
|---|---|
| February 23, 2021 | 169.62 |
| February 22, 2021 | 168.93 |
| February 19, 2021 | 171.53 |
| February 18, 2021 | 164.06 |
| February 17, 2021 | 166.30 |
| February 16, 2021 | 166.97 |
| February 12, 2021 | 173.08 |
| February 11, 2021 | 172.85 |
| February 10, 2021 | 176.96 |
| February 09, 2021 | 182.05 |
| February 08, 2021 | 185.94 |
| February 05, 2021 | 175.48 |
| February 04, 2021 | 165.79 |
| February 03, 2021 | 161.86 |
| February 02, 2021 | 161.93 |
| February 01, 2021 | 147.59 |
| January 29, 2021 | 145.87 |
| January 28, 2021 | 144.69 |
| January 27, 2021 | 142.56 |
| January 26, 2021 | 160.19 |
| January 25, 2021 | 139.58 |
| January 22, 2021 | 147.40 |
| January 21, 2021 | 140.95 |
| January 20, 2021 | 143.65 |
| January 19, 2021 | 147.19 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.584
Minimum
Oct 16 2019
185.94
Maximum
Feb 08 2021
38.69
Average
12.57
Median
Price to Book Value Benchmarks
| Pfizer Inc | 1.730 |
| Alnylam Pharmaceuticals Inc | -- |
| Tandem Diabetes Care Inc | 11.71 |
| Regenxbio Inc | 2.466 |
| IDEAYA Biosciences Inc | 3.289 |
Price to Book Value Related Metrics
| PS Ratio | 22.23 |
| PEG Ratio | -0.6663 |
| Price | 28.74 |
| Earnings Yield | -11.22% |
| Market Cap | 5.372B |
| PEGY Ratio | -0.6663 |